ArriVent BioPharma, Inc. (AVBP)

NGM – Real Time Price. Currency in USD

31.34

-0.05 (-0.16%)

Market open: Aug 12, 2026, 12:50 PM EDT

31.39

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

-178M

-94M

-75M

-37M

Operating Income

-178M

-94M

-75M

-37M

Non-operating income, total

11M

14M

Pretax income

-166M

-80M

-69M

-37M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-166M

-80M

-69M

-37M

Discontinued operations

Net income

-166M

-80M

-69M

-37M

Dilution adjustment

Preferred dividends

ArriVent BioPharma, Inc. (AVBP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ArriVent BioPharma, Inc. (AVBP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

ArriVent BioPharma, Inc. (AVBP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ArriVent BioPharma, Inc. (AVBP)

Income Statement (Annual)

Income Statement (Annual)